Cephalon Oncology is committed to supporting you through the reimbursement process. We provide you with convenient resources that make reimbursement easier to understand. These services are offered through a reimbursement support program called TREANDA Reimbursement Expertise.

To get personalized support when submitting reimbursement claims for TREANDA, you can contact the Hotline toll-free:

TREANDA Reimbursement Expertise Hotline
Phone: 1-888-5-TREANDA (1-888-587-3263)
Fax: 1-866-676-4073

TREANDA Reimbursement Expertise counselors are available by phone Monday through Friday, from 9 am to 8 pm Eastern Time. They can help with the following:

• Benefit verification and coverage
• Policy benefits and limitations
• Pre-certifications/prior authorizations
• Drug and services coding information
• Coverage guidelines and claim requirements of payors
• Support throughout the claims process
• Requested information needed to support claims submission
• Appeal support
• TREANDA Patient Assistance Program

When calling about patient-specific reimbursement issues, it may be necessary to have the following available:

• Patient's name, address, telephone number, date of birth, social security number, diagnosis, therapy start date, and expected course of treatment
• Name and telephone number of payor plan(s), policy number(s), and name of subscriber
• Physician's name, address, and telephone number

For coverage verifications and prior authorization or appeal support, patients will need to review and sign the enrollment form and fax or mail it to TREANDA Reimbursement Expertise.

Cephalon can assist with but cannot formally make appeals for callers, nor does it guarantee success in obtaining insurance authorizations or payments. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by the TREANDA Reimbursement Expertise Hotline staff.

Click here to review the TREANDA Physician Office Coding Guide for 2008.

Click here to review the TREANDA Hospital Outpatient Coding Guide for 2008.

TREANDA is indicated for the treatment of chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established.

The most common adverse events were myelosuppression, fever, nausea, and vomiting. Please see full Prescribing Information.